Crucible · Firm report card

Genaissance Pharmaceuticals

CT · SBIR awardee across 3 federal programs (DOE, NSF, HHS/NIH), first award 1985.

19SBIR awards

$4MSBIR $

14 → 5Phase I → II

$0Follow-on federal $

0Follow-on contracts

SBIR awards by program

Program	Awards	SBIR $	Phase I	Phase II
DOE	2	$825,000	1	1
NSF	1	$65,000	1	0
HHS/NIH	16	$3M	12	4

Mission areas

Buildings & Efficiency
Chemistry & Chemical Processes
Genomics & Cell Therapy
Infectious Disease & Vaccines
Oncology & Cancer

Open the interactive profile of Genaissance Pharmaceuticals →

Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.

Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology